FAQs about Ingredient Management
Starting from May 1, 2021, when applying for registration and notification, registrants and notifiers shall fill in the source and the trade name of ingredients used in the formula. Among them, if the ingredients have quality specifications as per the Safety and Technical Standards for Cosmetics 2015 (STSC 2015), quality specification certificates or safety-related information of the ingredients shall be submitted as well.
These specified ingredients include but not limited to Polyacrylamides, Trialkylamines, Trialkanolamines and their salts, Dichloromethane, Fatty acid Dialkylamides and Dialkanolamides, Monoalkylamines, Monoalkanolamines and their salts, etc. The specification requirements for these ingredients can be found under "Other Restrictions and Requirements" in the "Restricted Ingredients for Cosmetics" (List 3) of STSC 2015.
There are 17 ingredients newly defined as prohibited ingredients in Inventory of Existing Cosmetic Ingredients in China 2021 (IECIC 2021) since May 28, 2021, including Formaldehyde, Boric Acid, Sodium Borate, 2-Chloro-p-penylenediamine, 2-Chloro-p-phenylenediamine Sulfate, Cannabis Sativa Fruit, Cannabis Sativa Seed Oil, Cannabis Sativa Leaf Extract, Tagetes Erecta Flower Extract, Vinyl Acetate, etc. Cosmetics manufacturers shall not manufacture or import cosmetics containing these prohibited ingredients.
In Inventory of Existing Cosmetic Ingredients in China 2015 (IECIC 2015), there are cases where the same ingredient has multiple Chinese names. Therefore, IECIC 2021 standardizes and unifies the names of the same ingredient. The ingredients subject to the name change are compiled in the table below. From May 1, 2021, when applying for registration and notification, registrants and notifiers shall use the updated ingredient names as per IECIC 2021.
The changes are shown in red:
| No. | Cancelled Former Names | After Change |
| 1 | 白茅根提取物 IMPERATA CYLINDRICA MAJOR EXTRACT | 白茅根提取物 IMPERATA CYLINDRICA ROOT EXTRACT |
| 2 | 柏子仁提取物 PLATYCLADUS ORIENTALIS EXTRACT | 侧柏种仁提取物 PLATYCLADUS ORIENTALIS KERNEL EXTRACT |
| 3 | 独活提取物 ANGELICA PUBESCENS EXTRACT | 重齿毛当归提取物 ANGELICA PUBESCENS EXTRACT |
| 4 | 番茄提取物 SOLANUM LYCOPERSICUM EXTRACT | 番茄提取物 LYCOPERSICON ESCULENTUM EXTRACT |
| 5 | 芝麻提取物 SESAMUM INDICUM EXTRACT | 黑芝麻提取物 SESAMUM INDICUM EXTRACT |
| 6 | 化州柚提取物 CITRUS GRANDIS EXTRACT | 柚提取物 CITRUS GRANDIS EXTRACT |
| 7 | 韭菜子提取物 ALLIUM TUBEROSUM EXTRACT | 韭菜籽提取物 ALLIUM TUBEROSUM SEED EXTRACT |
| 8 | 荔枝核提取物 LITCHI CHINENSIS EXTRACT | 荔枝籽提取物 LITCHI CHINENSIS SEED EXTRACT |
| 9 | 凌霄花提取物 CAMPSIS GRANDIFLORA EXTRACT | 凌霄花提取物 CAMPSIS GRANDIFLORA FLOWER EXTRACT |
| 10 | 芦根提取物 PHRAGMITES COMMUNIS EXTRACT | 芦苇根提取物 PHRAGMITES COMMUNIS ROOT EXTRACT |
| 11 | 绿壳砂仁提取物 AMOMUM VILLOSUM XANTHIOIDES EXTRACT | 绿壳砂果提取物 AMOMUM VILLOSUM XANTHIOIDES FRUIT EXTRACT |
| 12 | 美洲凌霄花提取物 CAMPSIS RADICANS EXTRACT | 美洲凌霄花提取物 CAMPSIS RADICANS FLOWER EXTRACT |
| 13 | 青蒿提取物 ARTEMISIA ANNUA EXTRACT | 黄花蒿提取物 ARTEMISIA ANNUA EXTRACT |
| 14 | 山里红果提取物 CRATAEGUS PINNATIFIDA FRUIT EXTRACT | 山楂果提取物 CRATAEGUS PINNATIFIDA FRUIT EXTRACT |
| 15 | 山药块茎提取物 DIOSCOREA OPPOSITA TUBER EXTRACT | 薯蓣块茎提取物 DIOSCOREA OPPOSITA TUBER EXTRACT |
| 16 | 山银花提取物 LONICERA CONFUSA EXTRACT | 华南忍冬花提取物 LONICERA CONFUSA FLOWER EXTRACT |
| 17 | 首乌藤提取物 POLYGONUM MULTIFLORUM EXTRACT | 何首乌藤茎提取物 POLYGONUM MULTIFLORUM STEM EXRACT |
| 18 | 素馨花提取物 JASMINUM OFFICINALE GRANDIFLORUM EXTRACT | 素馨花提取物 JASMINUM GRANDIFLORUM EXTRACT |
| 19 | 莎草提取物 CYPERUS ROTUNDUS EXTRACT | 香附提取物 CYPERUS ROTUNDUS EXTRACT |
| 21 | 薏苡仁提取物 COIX LACRYMA-JOBI MA-YUEN EXTRACT | 薏苡提取物 COIX LACRYMA-JOBI EXTRACT |
FAQs about Ingredient Submission Code
It has been found that the ingredient submission code provided for some cosmetics' notification application on the Cosmetics Registration and Notification Platform is inconsistent with the data stored in the Cosmetic Ingredient Safety Information Submission Platform (the submission platform). Notifiers need to confirm with ingredient manufacturers or suppliers about:
(1) Whether the ingredient submission code corresponds with the target ingredient;
(2) Whether the specific ingredients in cosmetic formula, such as the composition and proportion of compound ingredients, are consistent with the information provided on the submission platform.
Yes. The Cosmetics Registration and Notification Platform accepts multiple submission codes for one ingredient.
Others
Article 23 of Cosmetic Supervision and Administration Regulation (CSAR) stipulates that overseas cosmetics registrants and notifiers shall designate an enterprise legal person in the territory of China to handle cosmetics registration and notification, and assist in monitoring of cosmetics adverse reactions and implementing product recalls. For general cosmetics entrusted to be produced in China, overseas cosmetic notifiers shall designate an enterprise legal person in the territory of China as the domestic responsible person (RP). The RP shall register an account on the Cosmetics Registration and Notification Platform prior to handling the notification of entrusted produced cosmetics on behalf of the overseas notifiers.
As required by Article 37 of Provisions for Management of Cosmetic Registration and Notification Dossiers (Provisions), special cosmetics and general cosmetics for export only shall be notified on the Cosmetics Registration and Notification Platform. Cosmetics manufacturers shall submit the following documents:
(1) Product name;
(2) The country (region) to be exported to;
(3) Product's label pictures, including the front stereoscopic display diagram of the product sales packaging, the product packaging plan, and the product leaflet (if any).
According to Standards for Cosmetic Efficacy Claim Evaluation, cosmetic registrants and notifiers can carry out cosmetic efficacy claim evaluation by themselves or by entrusting an evaluation institution with required capabilities. Institutions that undertake the cosmetic efficacy claim evaluation shall establish good laboratory practices, complete the efficacy claim evaluation and issue the reports, and be responsible for the authenticity and reliability of the reports.
Cosmetics with freckle-removing and whitening, sunscreen or anti-hair loss efficacy shall undergo the human trial carried out by cosmetics registration and notification testing institutions in accordance with the requirements of mandatory national standards and technical norms, with a report issued.
Yes. The Provisions specifies that, when filling out the formula table on the Cosmetics Registration and Notification Platform, cosmetic registrants and notifiers shall indicate the contents of all ingredients, which are calculated by the mass percentage. In addition, all ingredients shall be listed in descending order as per the contents’ mass percentage. Subject to this requirement, ingredients whose content are less than 0.1% shall also be arranged in descending order.
However, when label the product formula, according to Administrative Measures on Cosmetics Labeling, cosmetic registrants and notifiers shall label ingredients whose content is no more than 0.1% (w/w) separately with "other trace ingredients" as the guide language, and these ingredients do not have to be listed in descending order of content in formula.
No. Article 30 of the Provisions states that the main procedures of the actual production process shall be briefly described, including feeding, blending, filling, etc. If there is a freeze-drying process involved, it shall be described based on the actual production process as well.


Request a Demo

We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by 





